💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Myriad Genetics, Inc. (MYGN)
« Back to company indexMYGN Chatter Timeline
Stock Ticker for MYGN
Most Active Tweeters for MYGN
| User | Tweets |
|---|---|
| @Tickeron | 4 |
| @FlashAlert_me | 3 |
| @phasefivebot | 2 |
| @SmallCapsDaily | 2 |
| @RamUltraAlgo | 2 |
Recent Tweets for MYGN
 |
@TradeFlags #DeathCross $MYGN at 25.53 R11 HiLo 42% T1Y 30 hold 3.2 fwdPE 134.4 DIV N/A #Myriad Gen #stocks #trading #finance… https://t.co/gMsIRM4bCl December 3rd 2021, 6:12am |
 |
@FlashAlert_me $MYGN [15s. delayed] filed SEC form 4: Chief People Officer Hart Jayne B.: Granted 143 of Common Stock at price $2… https://t.co/wdP9J5vtNk December 1st 2021, 11:12pm |
 |
@LeviTrade2 $MYGN Awaiting buy Signal. Stock Trading Ideas by https://t.co/TpxWPHxKVP #Investing #trading https://t.co/rSS2xz8Kld November 30th 2021, 12:11pm |
 |
@RamUltraAlgo Waiting for Buy signal on $MYGN https://t.co/K40BqPufIA November 29th 2021, 6:11pm |
 |
@Tickeron $MYGN's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/DDo5iiovaz November 24th 2021, 8:11pm |
 |
@ShogunTrade $MYGN Awaiting buy signal. Trading simplified, free trial at https://t.co/6vnULU2sSf https://t.co/mFsZUoqtMi November 24th 2021, 12:11pm |
|
@RamUltraAlgo Waiting for Buy signal on $MYGN https://t.co/nhNZ5PYMhC November 23rd 2021, 6:11pm |
 |
@SmallCapsDaily $MYGN The New Generation Gap: Nationwide Survey Finds Different Perspectives on Anxiety Between Parents, Young Adul… https://t.co/ILY3kSwhn4 November 23rd 2021, 3:11pm |
 |
@phasefivebot $MYGN The New Generation Gap: Nationwide Survey Finds Different Perspectives on Anxiety Between Parents, Young Adul… https://t.co/T1soYI71f0 November 23rd 2021, 12:11pm |
|
@FlashAlert_me $MYGN [15s. delayed]: Issued Press Release on November 23, 07:05:00: The New Generation Gap: Nationwide Survey Find… https://t.co/4mp6o3bwq1 November 23rd 2021, 12:11pm |
|
@Tickeron $MYGN's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds f… https://t.co/rzCcgxhbpo November 22nd 2021, 7:11pm |
 |
@MarcJacksonLA $MYGN Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Value of Genetic Test… https://t.co/SxtHLwQ4eD November 22nd 2021, 5:11pm |
|
@Tickeron A.I.dvisor made a bearish call on $MYGN, netting in a 18.50% gain over 1 month #MyriadGenetics #stockmarket #stock… https://t.co/iWgUgPNMKN November 22nd 2021, 5:11pm |
|
@SmallCapsDaily $MYGN Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Value of Genetic Test… https://t.co/uocUyFAJiH November 22nd 2021, 3:11pm |
 |
@63_hyacinth Myriad Genetics to present new data at SABCS $MYGN November 22nd 2021, 12:11pm |
|
@phasefivebot $MYGN Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Value of Genetic Test… https://t.co/rx0CKcnQLE November 22nd 2021, 12:11pm |
|
@FlashAlert_me $MYGN [15s. delayed]: Issued Press Release on November 22, 07:05:00: Myriad Genetics to Present New Data at San Ant… https://t.co/jzvfq3zMXp November 22nd 2021, 12:11pm |
 |
@StockNewsBot2 $MYGN Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Value of Genetic Test… https://t.co/Qscj4oWKGr November 22nd 2021, 12:11pm |
 |
@quantisnow $MYGN ? Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Value of Genetic Te… https://t.co/RqFKzF624U November 22nd 2021, 12:11pm |
 |
@stock_titan $MYGN Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Value of Genetic Test… https://t.co/qhgd1XQecc November 22nd 2021, 12:11pm |
|
@Tickeron A.I.dvisor made a bearish call on $MYGN, netting in a 18.89% gain over 3 months #MyriadGenetics #stockmarket #stock… https://t.co/Oi84mVZCn3 November 22nd 2021, 7:11am |
 |
@nanalyzetweets Myriad Genetics $MYGN and Invitae $NVTA are two #Genetics companies that are competitors in the #PrecisionMedicine… https://t.co/oM2FaWTKTS November 21st 2021, 8:11pm |
 |
@ShortAlgoTrades $MYGN Awaiting Buy Signal. Stock Trading Ideas by https://t.co/jpmUt7BvVp https://t.co/Uw6lSoDtzr November 17th 2021, 1:11pm |
|
@RamUltraAlgo Waiting for Buy signal on $MYGN https://t.co/buF8ICOy9y November 16th 2021, 5:11pm |
 |
@TradeWithAlerts A nice print for $MYGN at 4:00pm -- SIDE: Bid Click https://t.co/oF1AMkOgf0 for more. Runners ?:… https://t.co/itn5x9uMoi November 15th 2021, 9:11pm |
|
@Tickeron $MYGN enters a Downtrend as Momentum Indicator dropped below the 0 level on November 11, 2021. View odds for this a… https://t.co/YH3Duq3IHG November 14th 2021, 7:11pm |
 |
@ChartMill $MYGN has a Profit Margin of -12.04%. This is amongst the best returns in the industry. https://t.co/LPOKuwrjQn https://t.co/PY2S7WpRpT November 13th 2021, 9:11am |
|
@nanalyzetweets Myriad Genetics $MYGN is getting schooled by Invitae, at least when it comes to revenue growth. Here's why… https://t.co/6w60t6VVjY November 12th 2021, 7:11pm |
|
@ShortAlgoTrades $MYGN Awaiting Short Signal. Algo Trading by https://t.co/jpmUt7BvVp https://t.co/Gq2cLK4M7W November 10th 2021, 1:11pm |
|
@RamUltraAlgo Waiting for Short signal on $MYGN https://t.co/fqhKSJD06F November 9th 2021, 6:11pm |
|
@Tickeron $MYGN in Uptrend: Stochastic indicator peaks and leaves oversold zone. View odds for this and other indicators:… https://t.co/rWY7o9Q0H7 November 7th 2021, 3:11pm |
|
@Tickeron $MYGN in Uptrend: Stochastic indicator peaks and leaves oversold zone. View odds for this and other indicators:… https://t.co/baDqDPkuKv November 6th 2021, 6:11pm |
 |
@transcriptoad Dr. Tiffany Traina introducing Dr. Mark Robson on “genetic testing for all breast cancer patients” $nvta $mygn… https://t.co/brgvQ8rHyN November 4th 2021, 9:11pm |
 |
@fintel_io $MYGN / Myriad Genetics files form 10-Q https://t.co/10uBQNeH4w #FNTL November 4th 2021, 8:11pm |
|
@RamUltraAlgo Waiting for Short signal on $MYGN https://t.co/Kf3HlgpoKe November 4th 2021, 6:11pm |
 |
@SismasStock $MYGN waiting for Buy signal on MYGN https://t.co/E3S7SzchsR November 3rd 2021, 7:11pm |
 |
@CFinancialNews Myriad Genetics $MYGN Given New $35.00 Price Target at SVB Leerink https://t.co/r8sblLbSnW #markets November 3rd 2021, 3:11pm |
 |
@AmericanBanking Myriad Genetics $MYGN Given New $35.00 Price Target at SVB Leerink https://t.co/Tne7HebjVp #stocks November 3rd 2021, 3:11pm |
 |
@Jarvis_Alerts $MYGN [Myriad Genetics]: SVB Leerink Maintains Market Perform Lowers Price Target $36 --> 35 Sign-up free for bet… https://t.co/AwfoPD4UaU November 3rd 2021, 11:11am |
|
@quantisnow $MYGN ? SVB Leerink reiterated coverage on Myriad Genetics with a new price target https://t.co/U9zJEilBGo 30 seconds delayed. November 3rd 2021, 9:11am |
 |
@StckPro $MYGN NEW ARTICLE : Myriad Genetics, Inc. (MYGN) CEO Paul Diaz on Q3 2021 Earnings Call Transcript… https://t.co/kLm8KNKqPS November 3rd 2021, 1:11am |
 |
@SeekingAlpha $MYGN - Myriad Genetics, Inc. (MYGN) CEO Paul Diaz on Q3 2021 Earnings Call Transcript. https://t.co/Y9ibAFJlBi… https://t.co/TevuEmedFI November 3rd 2021, 1:11am |
|
@SeekingAlpha $MYGN - Myriad Genetics, Inc. 2021 Q3 - Results - Earnings Call Presentation. https://t.co/j69xq1GJDF #stockmarket #business #trading November 3rd 2021, 1:11am |
 |
@EarningsAlley Myriad Genetics, Inc. $MYGN held an earnings call on 11/2/2021. Here are the highlights: November 3rd 2021, 12:11am |
 |
@myriadgenetics Myriad Genetics Third Quarter 2021 Financial Results Conference Call. Click here for webcast: https://t.co/PlnnXdu4co $MYGN November 2nd 2021, 8:11pm |
|
@SmallCapsDaily $MYGN Myriad Genetics Reports Third Quarter 2021 Results, Continues Strong Execution of Strategic Growth & Transfor… https://t.co/vul40MVgiE November 2nd 2021, 5:11pm |
 |
@Briefingcom $MYGN: Myriad Genetics misses by $0.01, reports revs in-line https://t.co/67McDYDmUn November 2nd 2021, 2:11pm |
|
@MarcJacksonLA $MYGN Myriad Genetics Reports Third Quarter 2021 Results, Continues Strong Execution of Strategic Growth & Transfor… https://t.co/HtzbtF8INu November 2nd 2021, 12:11pm |
 |
@investor_feed $MYGN 8-K Myriad Genetics (2 Nov, 8:40am) ? Continues Strong Execution of Strategic Growth & Transformation Pl… https://t.co/P9zMDUYDGT November 2nd 2021, 12:11pm |
|
@63_hyacinth Myriad Genetics reports Q3 adjusted EPS (2c), consensus (2c) $MYGN November 2nd 2021, 12:11pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?